ACUTE CORONARY SYNDROME

This study looks at a special stent (a small mesh tube) coated with a drug called sirolimus, used to open blocked heart arteries. Researchers will follow 300 adults who received this stent during a standard heart procedure to see how safe and effective it is over 5 years. The mai…

This study tests a drug called pelacarsen in people who recently had a heart attack and have high levels of Lp(a), a type of fat in the blood that raises heart risk. The goal is to see if the drug can safely lower Lp(a) levels and improve heart health. About 240 adults in the US …

This study tests whether a wearable monitoring system (ECG patch, temperature patch, and pulse oximeter) can reduce major heart complications in hospitalized patients with heart disease. About 1500 adults will be monitored either with standard care (vital signs every 4-8 hours) o…

This study tests whether using a patient's genetic information to choose anti-platelet drugs can lower bleeding risks compared to standard care. About 1,760 high-risk patients receiving a heart stent will be assigned to either a personalized drug plan or usual therapy. The goal i…

This study looks at 4,400 people who had a heart attack and got a stent. It tests two drug strategies: one to lower bleeding risk by adjusting blood thinners, and another to lower cholesterol using a milder statin plus ezetimibe. The goal is to find the safest and most effective …

This pilot study tests whether taking a synbiotic supplement (a mix of probiotics and prebiotics) for 10 weeks can lower TMAO levels and improve other heart health markers in 80 adults who recently had a heart attack. The goal is to see if changing gut bacteria can help prevent f…

This study tests whether adding a PCSK9 inhibitor (a strong cholesterol-lowering drug) to standard statin therapy can stabilize fatty plaques in the arteries of people who recently had a heart attack. About 212 participants will receive either the drug combination or standard car…

This study tests whether digital health tools can help people recover safely at home after a heart attack. Researchers will compare two types of follow-up care: education alone versus education plus extra support like symptom tracking and virtual appointments. The goal is to redu…

This study aims to see if a simple breath test can help doctors quickly tell which patients with chest pain are at high risk for a heart attack or other serious condition. Researchers will collect breath samples from 6,000 adults coming to the emergency room with chest pain and a…

This study tests whether an artificial intelligence (AI) tool can help emergency room doctors interpret heart CT scans more accurately. About 530 adults with chest pain and intermediate risk of a heart attack will be randomly assigned to have their scans read with or without AI a…

This study looks at whether two blood markers – mean platelet volume (MPV) and the systemic inflammatory response index (SIRI) – can help diagnose and predict outcomes in people with acute coronary syndrome (heart attack or unstable angina). Researchers will measure these markers…

This study will enroll 144 adults with acute coronary syndrome (heart attack or unstable angina) to see how inflammatory markers (hs-CRP and neutrophil-to-lymphocyte ratio) and cardiac troponin levels relate to heart function measured by echocardiography. Researchers hope to impr…

This study looks at a protein called GARP and related inflammatory markers in the blood of 600 adults with either acute (sudden) or chronic (long-term) coronary syndrome. Participants will have blood drawn during a routine heart catheterization. The goal is to understand how GARP…

This study will follow 1200 people who have had a heart attack or unstable angina and also have sleep apnea. Researchers will collect blood, urine, and stool samples to understand how sleep apnea affects metabolism and heart risk. The goal is to build an AI-based tool to better p…

This study tests a patient decision aid designed to help heart attack survivors with high bleeding risk choose the best blood-thinner plan. The tool explains risks and options so patients can share their preferences with doctors. The trial will enroll 26 participants to see if th…

This study will collect blood samples from 30,000 adults in the UK with various health conditions, including blood clots, infections, heart disease, diabetes, and more. The samples will be used to develop and fine-tune new diagnostic tests for the cobas® lumira device, which allo…

This study will enroll 850 adults over 65 who have had a heart attack (acute coronary syndrome). Researchers want to see if adding frailty measurements to standard risk scores improves the prediction of serious bleeding during the hospital stay and up to 6 months later. The goal …